Home › Research › Cass Review

Cass Review: The Report That Destroys the Affirmative Model (NHS, 2024)

The Cass Review is the most thorough investigation ever into the medical transition of children. Pediatrician Hilary Cass's conclusion: the evidence base is "remarkably weak." Puberty blockers and cross-sex hormones in minors rest on a handful of studies of low to very low quality. The NHS removed blockers from research and closed GIDS. Four European countries plus the United Kingdom have now, independently of each other, drawn the same conclusion: the affirmative model is not medicine; it is an ideological belief disguised as care.

Assignment and method

In 2020, the British NHS commissioned pediatrician Hilary Cass to conduct an evaluation of care for children with gender dysphoria. The final report was published in April 2024 after four years of work. The Cass team had seven systematic reviews conducted by the University of York—including reviews of puberty blockers, cross-sex hormones, social transition, and guidelines. The difference from previous "reviews" in the affirmative field: here, GRADE methodology was consistently applied.

The result is a diagnosis of a sector that has never seriously evaluated itself. 98 percent of the studies on puberty blockers and 99 percent of those on cross-sex hormones were of low or very low quality. The so-called "international consensus" on which WPATH relies turns out to consist of overlapping guidelines without an independent evidence basis — a methodological form of circular reasoning .

Key conclusions

• The scientific basis for puberty blockers and hormones in minors is "remarkably weak".
• No evidence that puberty blockers are psychologically beneficial or prevent suicide — the central selling point of the affirmative model is unproven.
• Social transition is not a neutral act — it steers psychological development in one direction and makes desistance more difficult. See desistance research .
• Comorbidity (autism, depression, anxiety, eating disorders, trauma) is systematically undertreated; affirmation treats the symptom, not the cause.
• The gender-affirmative model has a tone of certainty that is not supported by any evidence base.

Consequence: NHS reverses medical transition policy

The NHS scrapped puberty blockers outside of research settings for minors, closed the Tavistock Clinic (GIDS) , and is building a regional model in which psychological care comes first. In doing so, the UK is following a pattern that had already begun in Scandinavia: Sweden (SBU 2022) , Finland (COHERE 2020) , Norway (Ukom 2023) , and Denmark (2023) independently reached the same conclusion. Four Scandinavian countries plus the UK — all evidence-based health systems — have rolled back medical interventions for minors.

Response from WPATH and the Dutch lobby: negative

WPATH and the Dutch proponents of the affirmative model attempted to dismiss the report as "biased" or "transphobic." Substantive refutation was lacking—which was impossible anyway, since the methodology of York and Cass is public and replicable. At the same time, the WPATH Files show that WPATH itself had systematic reviews suppressed that turned out unfavorably for its own model. That is no longer a scientific organization; that is a lobbying group. See also the versions of the WPATH SOC and how the bar of proof was systematically lowered between 2011 and 2022.

What this means for the Netherlands

The Netherlands is the birthplace of the Dutch Protocol — and clings to the now-refuted claim that blockers provide a "thinking break." The VUmc protocol has been internationally falsified by Cass, Ukom, and SBU. The Dutch rollout via VUmc, UMCG, and regional clinics continued while the evidence base for the treatment disappeared. Anyone who takes children with gender dysphoria seriously treats the comorbidity first and leaves the body alone.